About Us Services Careers FAQ Contact Us 0
Home Medical Devices Global mTPE Device Market Size, Share, Growth, Forecast to 2032
mTPE Device Market

mTPE Device Market Size, Share & Trends Analysis Report By Therapeutic Application (Plasma or red cell exchange, Cell depletion, Granulocyte collection, Stem cell collection), By Therapeutic Type (Hemophilia, Bone marrow, Platelet transfusion, Renal dialysis), By End-User (Hospitals, Research Laboratories, Blood bank, Blood transfusion laboratories) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2024-2032

Report Code: SRMD1219DR
Last Updated : August 12, 2024
Author : Straits Research
Starting From
USD 2300
Buy Now
File Formats

Table Of Content

  1. Executive Summary
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
    1. North America
    2. Europe
    3. APAC
    4. Middle East and Africa
    5. LATAM
  2. ESG Trends
    1. Global mTPE Device Market Introduction
    2. By Therapeutic Application
      1. Introduction
        1. Therapeutic Application By Value
      2. Plasma or red cell exchange
        1. By Value
      3. Cell depletion
        1. By Value
      4. Granulocyte collection
        1. By Value
      5. Stem cell collection
        1. By Value
    3. By Therapeutic Type
      1. Introduction
        1. Therapeutic Type By Value
      2. Hemophilia
        1. By Value
      3. Bone marrow
        1. By Value
      4. Platelet transfusion
        1. By Value
      5. Renal dialysis
        1. By Value
    4. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospitals
        1. By Value
      3. Research Laboratories
        1. By Value
      4. Blood bank
        1. By Value
      5. Blood transfusion laboratories
        1. By Value
    1. Introduction
    2. By Therapeutic Application
      1. Introduction
        1. Therapeutic Application By Value
      2. Plasma or red cell exchange
        1. By Value
      3. Cell depletion
        1. By Value
      4. Granulocyte collection
        1. By Value
      5. Stem cell collection
        1. By Value
    3. By Therapeutic Type
      1. Introduction
        1. Therapeutic Type By Value
      2. Hemophilia
        1. By Value
      3. Bone marrow
        1. By Value
      4. Platelet transfusion
        1. By Value
      5. Renal dialysis
        1. By Value
    4. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospitals
        1. By Value
      3. Research Laboratories
        1. By Value
      4. Blood bank
        1. By Value
      5. Blood transfusion laboratories
        1. By Value
    5. U.S.
      1. By Therapeutic Application
        1. Introduction
          1. Therapeutic Application By Value
        2. Plasma or red cell exchange
          1. By Value
        3. Cell depletion
          1. By Value
        4. Granulocyte collection
          1. By Value
        5. Stem cell collection
          1. By Value
      2. By Therapeutic Type
        1. Introduction
          1. Therapeutic Type By Value
        2. Hemophilia
          1. By Value
        3. Bone marrow
          1. By Value
        4. Platelet transfusion
          1. By Value
        5. Renal dialysis
          1. By Value
      3. By End-User
        1. Introduction
          1. End-User By Value
        2. Hospitals
          1. By Value
        3. Research Laboratories
          1. By Value
        4. Blood bank
          1. By Value
        5. Blood transfusion laboratories
          1. By Value
    6. Canada
    1. Introduction
    2. By Therapeutic Application
      1. Introduction
        1. Therapeutic Application By Value
      2. Plasma or red cell exchange
        1. By Value
      3. Cell depletion
        1. By Value
      4. Granulocyte collection
        1. By Value
      5. Stem cell collection
        1. By Value
    3. By Therapeutic Type
      1. Introduction
        1. Therapeutic Type By Value
      2. Hemophilia
        1. By Value
      3. Bone marrow
        1. By Value
      4. Platelet transfusion
        1. By Value
      5. Renal dialysis
        1. By Value
    4. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospitals
        1. By Value
      3. Research Laboratories
        1. By Value
      4. Blood bank
        1. By Value
      5. Blood transfusion laboratories
        1. By Value
    5. U.K.
      1. By Therapeutic Application
        1. Introduction
          1. Therapeutic Application By Value
        2. Plasma or red cell exchange
          1. By Value
        3. Cell depletion
          1. By Value
        4. Granulocyte collection
          1. By Value
        5. Stem cell collection
          1. By Value
      2. By Therapeutic Type
        1. Introduction
          1. Therapeutic Type By Value
        2. Hemophilia
          1. By Value
        3. Bone marrow
          1. By Value
        4. Platelet transfusion
          1. By Value
        5. Renal dialysis
          1. By Value
      3. By End-User
        1. Introduction
          1. End-User By Value
        2. Hospitals
          1. By Value
        3. Research Laboratories
          1. By Value
        4. Blood bank
          1. By Value
        5. Blood transfusion laboratories
          1. By Value
    6. Germany
    7. France
    8. Spain
    9. Italy
    10. Russia
    11. Nordic
    12. Benelux
    13. Rest of Europe
    1. Introduction
    2. By Therapeutic Application
      1. Introduction
        1. Therapeutic Application By Value
      2. Plasma or red cell exchange
        1. By Value
      3. Cell depletion
        1. By Value
      4. Granulocyte collection
        1. By Value
      5. Stem cell collection
        1. By Value
    3. By Therapeutic Type
      1. Introduction
        1. Therapeutic Type By Value
      2. Hemophilia
        1. By Value
      3. Bone marrow
        1. By Value
      4. Platelet transfusion
        1. By Value
      5. Renal dialysis
        1. By Value
    4. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospitals
        1. By Value
      3. Research Laboratories
        1. By Value
      4. Blood bank
        1. By Value
      5. Blood transfusion laboratories
        1. By Value
    5. China
      1. By Therapeutic Application
        1. Introduction
          1. Therapeutic Application By Value
        2. Plasma or red cell exchange
          1. By Value
        3. Cell depletion
          1. By Value
        4. Granulocyte collection
          1. By Value
        5. Stem cell collection
          1. By Value
      2. By Therapeutic Type
        1. Introduction
          1. Therapeutic Type By Value
        2. Hemophilia
          1. By Value
        3. Bone marrow
          1. By Value
        4. Platelet transfusion
          1. By Value
        5. Renal dialysis
          1. By Value
      3. By End-User
        1. Introduction
          1. End-User By Value
        2. Hospitals
          1. By Value
        3. Research Laboratories
          1. By Value
        4. Blood bank
          1. By Value
        5. Blood transfusion laboratories
          1. By Value
    6. Korea
    7. Japan
    8. India
    9. Australia
    10. Taiwan
    11. South East Asia
    12. Rest of Asia-Pacific
    1. Introduction
    2. By Therapeutic Application
      1. Introduction
        1. Therapeutic Application By Value
      2. Plasma or red cell exchange
        1. By Value
      3. Cell depletion
        1. By Value
      4. Granulocyte collection
        1. By Value
      5. Stem cell collection
        1. By Value
    3. By Therapeutic Type
      1. Introduction
        1. Therapeutic Type By Value
      2. Hemophilia
        1. By Value
      3. Bone marrow
        1. By Value
      4. Platelet transfusion
        1. By Value
      5. Renal dialysis
        1. By Value
    4. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospitals
        1. By Value
      3. Research Laboratories
        1. By Value
      4. Blood bank
        1. By Value
      5. Blood transfusion laboratories
        1. By Value
    5. UAE
      1. By Therapeutic Application
        1. Introduction
          1. Therapeutic Application By Value
        2. Plasma or red cell exchange
          1. By Value
        3. Cell depletion
          1. By Value
        4. Granulocyte collection
          1. By Value
        5. Stem cell collection
          1. By Value
      2. By Therapeutic Type
        1. Introduction
          1. Therapeutic Type By Value
        2. Hemophilia
          1. By Value
        3. Bone marrow
          1. By Value
        4. Platelet transfusion
          1. By Value
        5. Renal dialysis
          1. By Value
      3. By End-User
        1. Introduction
          1. End-User By Value
        2. Hospitals
          1. By Value
        3. Research Laboratories
          1. By Value
        4. Blood bank
          1. By Value
        5. Blood transfusion laboratories
          1. By Value
    6. Turkey
    7. Saudi Arabia
    8. South Africa
    9. Egypt
    10. Nigeria
    11. Rest of MEA
    1. Introduction
    2. By Therapeutic Application
      1. Introduction
        1. Therapeutic Application By Value
      2. Plasma or red cell exchange
        1. By Value
      3. Cell depletion
        1. By Value
      4. Granulocyte collection
        1. By Value
      5. Stem cell collection
        1. By Value
    3. By Therapeutic Type
      1. Introduction
        1. Therapeutic Type By Value
      2. Hemophilia
        1. By Value
      3. Bone marrow
        1. By Value
      4. Platelet transfusion
        1. By Value
      5. Renal dialysis
        1. By Value
    4. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospitals
        1. By Value
      3. Research Laboratories
        1. By Value
      4. Blood bank
        1. By Value
      5. Blood transfusion laboratories
        1. By Value
    5. Brazil
      1. By Therapeutic Application
        1. Introduction
          1. Therapeutic Application By Value
        2. Plasma or red cell exchange
          1. By Value
        3. Cell depletion
          1. By Value
        4. Granulocyte collection
          1. By Value
        5. Stem cell collection
          1. By Value
      2. By Therapeutic Type
        1. Introduction
          1. Therapeutic Type By Value
        2. Hemophilia
          1. By Value
        3. Bone marrow
          1. By Value
        4. Platelet transfusion
          1. By Value
        5. Renal dialysis
          1. By Value
      3. By End-User
        1. Introduction
          1. End-User By Value
        2. Hospitals
          1. By Value
        3. Research Laboratories
          1. By Value
        4. Blood bank
          1. By Value
        5. Blood transfusion laboratories
          1. By Value
    6. Mexico
    7. Argentina
    8. Chile
    9. Colombia
    10. Rest of LATAM
    1. mTPE Device Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    1. Baxter International Inc
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  3. Disclaimer

Related Reports

Global Report
Market OverviewThe global CPAP devices market size was valued at USD 4.75 billion in 2023. It is estimated to reach USD 9.67 billion by 2032, growing at a CAGR of 8.23% during the forecast period (2024–2032). Several key factors have contributed to t
Buy Now
Global Report
The global ENT devices market size was valued at USD 23.13 billion in 2022. It is estimated to reach USD 33.49 billion by 2031, growing at a CAGR of 4.2% during the forecast period (2023–2031). A rise in the prevalence of hearing loss/impairmen
Buy Now
Global Report
Market OverviewThe global orthopedic devices market size was valued at USD 60400 million in 2023. It is projected to reach USD 94060 million by 2032, growing at a CAGR of 5.3% throughout the forecast period (2024-2032).  Orthopedic devices are used
Buy Now

Purchase Benefits

  • Eligible for a free updated report next year
  • Completely customizable scope
  • 30% discount on your next purchase
  • Dedicated account manager
  • Query resolution within 24 hours
  • Permission to print the report

We are featured on :

www.straitsresearch.com
© Copyright 2025. All rights Reserved.